Objective: We aimed to discover the molecular mechanism of hsa_circ_0076694 (circRUNX2) on osteogenic differentiation. We also explored the interaction between circRUNX2, miR-203 and RUNX2. 
Recently much attention has been paid to Circular RNAs (circRNAs), which is one of a class of noncoding RNAs, with circular structure by joining the 3′end of the RNA to the 5′end. 4 They were important in regulating the expression of other genes. For example, Liu et al found 2:27713879|27755789 and 2:240822115| 240867796 participated in regulation network in osteogenic differentiation. 5 Also, they were able to affect the expression of some essential carcinogenic mRNAs by targeting miRNAs and changing the miRNAs expression which would subsequently change the miRNAs level. 6 It was predicted that circRNAs would combine with miRNA and compete for the binding sites on the miRNA with mRNAs. 7 CircRNAs expression would alter the mRNA expression by targeting miRNAs that were binding to the mRNAs chosen. For instance, it is reported that hsa_circRNA_103801, a novel circRNA, targeted genes which were mainly involved in biological processes and cellular components. 8 CircUBAP2 inhibited the expression of microRNA-143
(miR-143) giving rise to promote osteosarcoma growth and inhibit apoptosis both in vitro and in vivo. 9 Also, circRNA_0009910 was found to be overexpressed in osteosarcoma cells (OS cells), and knocking down of which inhibited cell proliferation, and induced cell cycle arrest as well as apoptosis in OS cells. It worked by targeting miR-449a, which had the opposite effect on OS cells. 10 These researches provide us great examples to deem that miRNA-circRNA interaction is considered to one of better direction for therapy.
Runt related transcription factor, known as RUNX factors, which proteins located in sub-nuclear domains and integrated cell signals during formation of gene promoter regulatory complexes. 11 RUNX2
is a member of the human RUNT related transcription factor family essential during embryogenesis for skeletal development. It was recognized on account of its oncogenic properties and many studies showed that a de-regulating of RUNX2 function leads to progression and invasion of different tumours. 12 Also, RUNX2 was reported to closely relate to bone formation and hypertrophic chondrocyte differentiation. 13 Some evidence showed that the down-regulated RUNX2 protein expression inhibited bone formation, and decreased bone mass. 14 Although there were already some researches on RUNX2-related regulation in osteogenic differentiation, the understanding towards to the mechanism of it was far from being comprehensive. Herein, we wanted to investigate the molecule mechanism of RUNX2 in the osteogenic differentiation.
In this study, we tried to find the expression levels of miR-203, circRUNX2, and RUNX2 in osteoporotic patients and how miR-203, circRUNX2, and RUNX2 affect each other expression levels to influence the development of the osteoporosis.
| MATERIALS AND METHODS

| Clinical samples
Trabecular bone samples from the trochanteric region of the femur at a site far from the periarticular bone were obtained from 20 patients undergoing hip replacement because of femoral neck fracture. A total of 10 osteoporotic specimens were collected from women aged 62-89 (average age: 75). Ten nonosteoporotic specimens derived from women patients with suffered external traumatic fracture. To keeping samples fresh, frozen environment was needed.
None of the patients underwent any medical treatment that affected bone or mineral metabolism before enrolling in this study. 
| Cell transfection
MiR-203 mimics, miR-203 inhibitor, miRNA control, plasmid mediated circRUNX2 overexpression, circRUNX2 siRNA, and control vector were purchased from Genechem (Shanghai, PR, China). HBMSCs were planted in 6-well plates for 24 hours prior to the transfection with 50%-60% confluence, and then were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions.
| QRT-PCR
Before extract of total RNA, the bone is rapidly placed in the mortar that is precooled with liquid nitrogen, and then repeatedly ground to the powder. Total RNA was extracted using TRIzol reagent (ThermoFisher, China) and cDNA was synthesized using iScript ™ cDNA Syn- 
| Biotin pull down assay
The pull-down assay with biotinylated RNA was performed as described. 16, 17 In brief, for circRUNX2 pulled down miRNAs, the ) . B, The detailed sequence information of miR-203 complemented with has_circ_0076694 (circRUNX2) and RUNX2. C, Lysates from hBMSCs with circRUNX2 overexpression were subject to biotinylated-circRUNX2 pull down assay and the expression levels of circRUNX2 were detected by qRT-PCR. ***P < 0.001, **P < 0.01. D, The expression of miR-203 were quantified by qRT-PCR after the biotinylated-circRUNX2 pull down assay in hBMSCs. ***P < 0.001. E, The biotinylated wild-type/mutant miR-203 was, respectively, transfected into hBMSCs with circRUNX2 overexpression. ***P < 0.001. 
| RNA fluorescence in situ hybridization (FISH)
The RNA fluorescence in situ hybridization assay was performed by 
| Alizarin red staining
Alizarin red staining (ARS) was performed to detect the osteoblast calcification. For ARS, hBMSCs were seeded at a density of 
| Statistical analysis
All experiments were repeated at least three times. Data were analysed using Graph Pad Prism 6.0 software. All data were presented as mean ± SD. Differences between two groups were identified by unpaired t test, and differences between more than two groups were analysed using one-way analysis of variance (ANOVA).
F I G U R E 4 CircRUNX2 affected osteogenic differentiation through regulating miR-203. (A, B and C) CircRUNX2 and RUNX2 expressions
were up-regulated, but miR-203 expression was down-regulated through inducing hBMSC osteogenic differentiation. **P < 0.01, *P < 0.05. D, Overexpressed circRUNX2 increased RUNX2 expression level and decreased miR-203 expression level in hBMSCs. ***P < 0.001, **P < 0.01, *P < 0.05. E, RUNX2 expression was inhibited by up-regulation of the miR-203 and promoted by down-regulation of the miR-203 in hBMSC. ***P < 0.001, **P < 0.01
Moreover, Spearman correlation analysis was used to detect the relationship between molecules. P < 0.05 was taken as statistically significant.
| RESULTS
| CircRUNX2 and RUNX2 was lowly expressed in osteoporotic patients
CircRUNX2 and RUNX2 mRNA expression levels was found to be lower in osteoporotic patients' bone tissues than nonosteoporotic bone tissues ( Figure 1A,B) . Spearman correlation analysis analysed correlation between circRUNX2 and RUNX2 which showed a positive relationship ( Figure 1C ). In addition, proteins of RUNX2, ALP, BSP, OCN, and OPN were detected by western blotting in osteoporotic and nonosteoporotic bone tissues. Results showed protein levels of RUNX2, BSP, OCN, and OPN was lower in osteoporotic bone tissues than that in nonosteoporotic bone tissues and ALP protein level was no obvious difference between osteoporotic and nonosteoporotic bone tissues ( Figure 1D ).
| MiR-203 contained the targets of circRUNX2 and RUNX2
MiRNAs targeting circRUNX2 were predicted by Home database. UTR (WT-RUNX2). MiR-203 level was also detected in osteoporotic patients, and osteoporotic patients were with a higher miR-203 level compared to nonosteoporotic patients ( Figure 3C ). Furthermore, the negative correlation relationship between RUNX2 mRNA and miR-203 were observed by Spearman correlation analysis in 10 clinical samples ( Figure 3D ).
| CircRUNX2 and miR-203 affected osteogenic differentiation through regulating RUNX2
The expression levels of circRUNX2, miR-203, and RUNX2 were detected at the 0 day, 7th days, 14th days, and 21th days of osteogenic differentiation. During hBMSCs osteogenic differentiation, circRUNX2 and RUNX2 expressions showed an increasing trend, but miR-203 expression was gradually decreased ( Figure 4A ,B,C). To further investigate the regulation links between circRUNX2, miR-203, and RUNX2, qRT-PCR assays were performed after regulating circRNUX2, miR-203, or RUNX2. Results showed that, in hBMSCs, circRUNX2 overexpression lead to the reduction in miR-203 and the increase in RUNX2 mRNA, circRUNX2 down-regulation caused the opposite results ( Figure 4D ). MiR-203 up-regulation inhibited RUNX2 expression, and miR-203 down-regulation promoted RUNX2 expression. In Addition, circRUNX2 was not regulated by miR-203 (Figure 4E) . Similarly, circRUNX2 and miR-203 were not regulated by RUNX2 ( Figure S1A ). to RUNX motif on promoter region of Fra-1, during the early period of osteogenic differentiation of C2C12 myogenic progenitor cells. 13 Yoon et al found that RUNX2 could be inhibited by NAA10 in the process of BMP-2-induced differentiation and bond growth. 18 Some studies showed that RUNX2 expression is up-regulated with RBM3
overexpression, which stimulated osteoblast differentiation; whereas the RUNX2 expression decreased in the presence of RBM3 inhibitor. 19 However, the RUNX2-related regulation mechanism is far from comprehensive. Herein, current study is aimed at investigating RUNX2-related regulation system during the progress of osteogenic by combining to miR-124 and reducing its activity. 21 Therefore, we continued to explore molecular mechanism during the progress of osteogenic differentiation with circRNA-miRNA-mRNA axis models.
In the past, some circRNAs, like circ19142 and circ5846, are reported to be involved in BMP2-reduced osteoblast differentiation, through a circ19142/circ5846-targeted miRNA-mRNA axis. 6 However, the role of circRNAs in this process, for instance, hsa-circ-0076694 (circRUNX2), remained to be researched. In this research, we focused on how circRUNX2 influenced osteoporosis and revealed the mechanism of osteogenic differentiation related to circRUNX2. We linked the correlation of circRUNX2 and RUNX2 and predicted their common targeting miRNA. What's more, we used, RNA pull down assay, RIP assay, RNA FISH assay, dual-Luciferase
Reporter assay, and functional experiments to verify our prediction.
The present research revealed the molecular regulation mechanism of circRUNX2/miR-203/RUNX2 axis during the progress of osteogenic differentiation, which will provide a novel therapy target for osteoporosis.
Although we tried to take all the factors into consideration in our experiments, some aspects could still be improved. For example, because of the difficulties in obtaining clinical samples, we only applied 10 osteoporosis specimens for our investigation. The conclusions would be more reliable on condition that there were more samples.
Furthermore, there are several other bone differentiation related proteins detected in our experiments, like BSP, OCN, and OPN. Thus, next experiment might focus on how circRUNX2 regulated these proteins and enrich the mechanism of osteoblast differentiation.
| CONCLUSION
This study mainly researches the effects of the circRUNX2 and its relations with other close genes. CircRUNX2 might prevent osteoporosis through regulating has-miR-203 and RUNX2. In order to get the more safe and effective therapies for osteoporosis, more circRNAs, mRNAs, and miRNAs should be researched to find out their effect and the links among them.
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